211
Views
3
CrossRef citations to date
0
Altmetric
Medical and Veterinary Mycology

In vitro and ex vivo antibiofilm activity of riparin 1, and its nor and dinor homologs, against dermatophytes

, , , , , , , & ORCID Icon show all
Pages 206-215 | Received 19 Nov 2022, Accepted 16 Jan 2023, Published online: 27 Feb 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (2)

Maria Lucilene Queiroz da Silva, Gabriela Ribeiro de Sousa, Natália Ferreira de Sousa, Antonia Thassya Lucas dos Santos, Henrique Douglas Melo Coutinho, José Maria Barbosa Filho, Jailton de Souza Ferrari, Marcus Tullius Scotti, João Batista Teixeira da Rocha & Maria Flaviana Bezerra Morais-Braga. (2024) In vitro inhibitory activity of Riparins against Candida spp. strains and in silico interaction with multi-drug-resistance proteins. Process Biochemistry 142, pages 46-61.
Crossref
Marcelo Antônio Nóbrega da Rocha, Emanuel Pereira Silva, Risley Nikael Medeiros Silva, Gabriela Ribeiro de Sousa, José Maria Barbosa-Filho, Mayara dos Santos Maia, Alberto Shellygton Lima, Jailton de Souza-Ferrari & Fillipe de Oliveira Pereira. (2024) Riparin II-type benzamides as novel antibiofilm agents against dermatophytes: chemical synthesis, in vitro , ex vivo and in silico evaluation . Journal of Antimicrobial Chemotherapy 79:3, pages 617-631.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.